Puy Laurent, Lamy Chantal, Canaple Sandrine, Arnoux Audrey, Laine Nicolas, Iacob Ella, Constans Jean-Marc, Godefroy Olivier
Department of Neurology and Functional Neuroscience Laboratory EA 4559, Amiens University Medical Center, Amiens, France.
Department of Neurology and Functional Neuroscience Laboratory EA 4559, Amiens University Medical Center, Amiens, France.
Am J Emerg Med. 2017 May;35(5):716-719. doi: 10.1016/j.ajem.2017.01.007. Epub 2017 Jan 10.
Following the reorganization of a University Medical Center onto a single campus, an Intensive Care Unit was created within the adult Emergency Department (ED ICU). We assessed the effects of these organizational changes on acute stroke management and the intravenous administration of recombinant tissue plasminogen activator (IV rtPA), as characterized by the thrombolysis rate, door-to-needle time (DNT) and outcome at 3months.
Between October 2013 and September 2015, we performed a retrospective, observational, single-center, comparative study of patients admitted for ischemic stroke and treated with IV rtPA during two 321-day periods (before and after the creation of the ED ICU). All patients with ischemic stroke were included. Multivariable logistic regression models were performed. The DNT was stratified according to a threshold of 60min. A favorable long-term outcome was defined as a modified Rankin score≤2 at 3months.
A total of 1334 ischemic stroke patients were included. Among them, 101 patients received IV rtPA. The frequency of IV rtPA administration was 5.8% (39 out of 676) before the creation of the ED ICU, and 9.3% (62 out of 668) afterwards (odds ratio (OR) [95% confidence interval (CI)]: 1.67 [1.08-2.60]; p=0.02). Additionally, the DNT was shorter (OR [95%CI]: 4.30 [1.17-20.90]; p=0.04) and there was an improvement in the outcome (OR [95%CI]=1.30 [1.01-2.10]; p=0.045).
Our results highlight the benefits of a separate ED ICU within conventional ED for acute stroke management, with a higher thrombolysis rate, reduced intrahospital delays and better safety.
在一所大学医学中心重组至单一校区后,在成人急诊科内设立了重症监护病房(急诊重症监护病房,ED ICU)。我们评估了这些组织架构变化对急性卒中管理以及重组组织型纤溶酶原激活剂(IV rtPA)静脉给药的影响,具体指标为溶栓率、门到针时间(DNT)以及3个月时的预后情况。
在2013年10月至2015年9月期间,我们对在两个321天时间段(急诊重症监护病房设立前后)因缺血性卒中入院并接受IV rtPA治疗的患者进行了一项回顾性、观察性、单中心比较研究。纳入所有缺血性卒中患者。进行多变量逻辑回归模型分析。DNT根据60分钟的阈值进行分层。良好的长期预后定义为3个月时改良Rankin评分≤2分。
共纳入1334例缺血性卒中患者。其中,101例接受了IV rtPA治疗。急诊重症监护病房设立前IV rtPA给药频率为5.8%(676例中的39例),之后为9.3%(668例中的62例)(优势比(OR)[95%置信区间(CI)]:1.67[1.08 - 2.60];p = 0.02)。此外,DNT更短(OR[95%CI]:4.30[1.17 - 20.90];p = 0.04),且预后有所改善(OR[95%CI]=1.30[1.01 - 2.10];p = 0.045)。
我们的结果凸显了在传统急诊科内设立独立急诊重症监护病房对急性卒中管理的益处,包括更高的溶栓率、减少院内延误以及更好的安全性。